The stock market indices started off the day with a little bit of a dip, with lower futures, and then exploded, testing the Nasdaq 100 all-time highs, but could not get through the 5427 area. The S&P 500 rallied sharply as well, but only did 50% of its drop from Friday afternoon, and then both indices rolled over sharply, reaching the Thursday’s lows on the Nasdaq 100 and the gap low on the S&P 500. Late in the day, they rallied, but in the last few minutes backed off again to close mixed on the day.

Net on the day, the Dow was down 8.76 at 20,905.86. The S&P 500 was down 4.78 at 2373.47. The Nasdaq 100 managed to gain 4.54 at 5413.31.

Advance-declines were 17 to 12 negative on the New York Stock Exchange, and 17 to 11 negative on the Nasdaq. Up/down volume was 18 to 11 negative on New York, total volume of just under 3 billion shares traded. The Nasdaq traded 1.7 billion shares and had a 9 to 8 positive volume ratio.

TheTechTrader.com board was mostly green. There were some big movers today, however, Priceline.com (PCLN) was down 7.19 to 1765.44, and Alphabet Inc. (GOOG) down 3.72 to 848.40, but Apple Inc. (AAPL) reached a new all-time high today, up 1.47 to 141.46, Amazon.com, Inc. (AMZN) also reached a new all-time high, up 4.66 to 866.97, Netflix, Inc. (NFLX) up 72 cents to 145.83.

Baidu, Inc. (BIDU) dropped 49 cents to 176.13, Facebook, Inc. (FB) eked out a dime to 139.94, and First Solar, Inc. (FSLR) went lower by 1.49 to 30.34.

Tesla Motors, Inc. (TSLA) gained 42 cents to 261.92.

The biotech’s had an especially good day today. Esperion Therapeutics, Inc. (ESPR) exploded on positive drug news, up 17.55 to 41.22, just a point off the session highs. Nektar Therapeutics (NKTR) gained 6.61 to 22.11, just pennies off the high. It was a monster day for both of those biotech’s that were swinging. NVIDIA Corporation (NVDA) ran 3.38 to 109.45, and Supernus Pharmaceuticals, Inc. (SUPN) closed up 1.00 to 29.90.

Other stocks to the upside included Shopify Inc. (SHOP), up 1.87 to 68.86.

On the downside, Clovis Oncology Inc (CLVS) lost 1.27 to 70.05.

Checking TheTechTrader.com percent-gain leaderboard, ViewRay, Inc. (VRAY) bounced 78 cents, or 13%, to 6.80, on 1.6 million shares traded.

Aurinia Pharmaceuticals Inc. (AUPH) advanced 1.08, or 14%, to 8.78, on almost 28 million shares traded.

CytomX Therapeutics, Inc. (CTMX) jumped 3.71, or 24%, to 18.89, on 2.3 million shares traded. Omeros Corporation (OMER) snapped back 1.21, or 11%, to 11.75, on 1.2 million shares traded.

Among other gainers, Blackhawk Network Holdings, Inc. (HAWK) was up 2.95 to 39.05.

The VelocityShares 3x Long Natural Gas ETN (UGAZ) closed up 2.20 to 19.66.

Stepping back and reviewing the hourly chart patterns, after an early dip and a very strong rally, the indices rolled over, took out the lows, and then took out support, only to snap back about 50% of the losses, still, ending mixed on the session.

Good Trading!

Harry

For more of Harry Boxer, sign up for a FREE 7-Day Trial to his Real-Time Technical Trading Diary.

(c) 2017 AdviceTrade, Inc. All rights reserved. Distributed only by written permission of AdviceTrade and The Technical Trader at info@advicetrade.com . In using any portion of Harry Boxer's content, you agree to the terms and conditions governing the use of the service as described in our disclaimer at http://www.thetechtrader.com

Mr. Boxer's commentaries and index analysis represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Trades mentioned on the site are hypothetical, not actual, positions.

Harry Boxer Archive

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2024 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.